SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ionis Pharmaceuticals Inc. – ‘8-K’ for 4/6/21 – ‘XML’

On:  Monday, 4/12/21, at 9:13pm ET   ·   As of:  4/13/21   ·   For:  4/6/21   ·   Accession #:  1193125-21-113586   ·   File #:  0-19125

Previous ‘8-K’:  ‘8-K’ on / for 4/6/21   ·   Next:  ‘8-K’ on / for 5/5/21   ·   Latest:  ‘8-K’ on 4/8/24 for 4/7/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/13/21  Ionis Pharmaceuticals Inc.        8-K:1,2,3,8 4/06/21   15:1.5M                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     46K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    457K 
 3: EX-10.1     Material Contract                                   HTML    169K 
 4: EX-10.2     Material Contract                                   HTML    179K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     15K 
 6: EX-99.2     Miscellaneous Exhibit                               HTML     18K 
11: R1          Document and Entity Information                     HTML     47K 
13: XML         IDEA XML File -- Filing Summary                      XML     13K 
10: XML         XBRL Instance -- d158901d8k_htm                      XML     14K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 8: EX-101.LAB  XBRL Labels -- ck0000874015-20210406_lab             XML     54K 
 9: EX-101.PRE  XBRL Presentations -- ck0000874015-20210406_pre      XML     34K 
 7: EX-101.SCH  XBRL Schema -- ck0000874015-20210406                 XSD     13K 
14: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
15: ZIP         XBRL Zipped Folder -- 0001193125-21-113586-xbrl      Zip    184K 


‘XML’   —   XBRL Instance — d158901d8k_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="ck0000874015-20210406.xsd" xlink:type="simple"/>
<context id="duration_2021-04-06_to_2021-04-06">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000874015 </identifier>
</entity>
<period>
<startDate> 2021-04-06 </startDate>
<endDate> 2021-04-06 </endDate>
</period>
</context>
<dei:EntityRegistrantName contextRef="duration_2021-04-06_to_2021-04-06" id="Hidden_dei_EntityRegistrantName"> IONIS PHARMACEUTICALS INC </dei:EntityRegistrantName>
<dei:AmendmentFlag contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:AmendmentFlag>
<dei:EntityCentralIndexKey contextRef="duration_2021-04-06_to_2021-04-06" id="Hidden_dei_EntityCentralIndexKey"> 0000874015 </dei:EntityCentralIndexKey>
<dei:DocumentType contextRef="duration_2021-04-06_to_2021-04-06"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="duration_2021-04-06_to_2021-04-06"> 2021-04-06 </dei:DocumentPeriodEndDate>
<dei:EntityIncorporationStateCountryCode contextRef="duration_2021-04-06_to_2021-04-06"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="duration_2021-04-06_to_2021-04-06"> 000-19125 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="duration_2021-04-06_to_2021-04-06"> 33-0336973 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="duration_2021-04-06_to_2021-04-06"> 2855 Gazelle Court </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="duration_2021-04-06_to_2021-04-06"> Carlsbad </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="duration_2021-04-06_to_2021-04-06"> CA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="duration_2021-04-06_to_2021-04-06"> 92010 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="duration_2021-04-06_to_2021-04-06"> (760) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="duration_2021-04-06_to_2021-04-06"> 931-9200 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="duration_2021-04-06_to_2021-04-06"> Common Stock, $.001 Par Value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="duration_2021-04-06_to_2021-04-06"> IONS </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="duration_2021-04-06_to_2021-04-06"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="duration_2021-04-06_to_2021-04-06"> false </dei:EntityEmergingGrowthCompany>
</xbrl>


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/21/24  Ionis Pharmaceuticals Inc.        10-K       12/31/23  103:18M
 2/22/23  Ionis Pharmaceuticals Inc.        10-K       12/31/22  110:25M
 2/25/22  Ionis Pharmaceuticals Inc.        10-K       12/31/21  106:22M
 8/05/21  Ionis Pharmaceuticals Inc.        S-8         8/05/21    3:71K                                    Broadridge Fin’l So… Inc
Top
Filing Submission 0001193125-21-113586   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 7:15:07.1pm ET